<style type="text/css">body .wpex-vc-row-stretched, body .vc_row-o-full-height { visibility: visible; }</style> skip to Main Content

Investor Contact

Institutional Investors, Financial Analysts or Retail Investors, please contact:

Galmed Investor Relations

Phone +972.3.693.84.48 
Fax +972.3.693.84.47

investor.relations@galmedpharma.com

Investor Disclaimer

This website, and specifically information included under the "For Investor" tab, may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward looking statements are based upon Galmed’s intent, beliefs or expectations as of the date of their release, but forward looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Applicable risks and uncertainties include risks and uncertainties associated with the initiation, timing, progress and results of Galmed’s research, preclinical studies and clinical trials as well as risks and uncertainties identified under the heading “Risk Factors” included in Galmed’s most recent Annual Report on Form 20-F filed with the Securities and Exchange Commission and in other filings that Galmed has made and may make with the SEC in the future.

* Required Fields
Back To Top